Dan tested Codex 5.3 on Proof, a macOS markdown editor that he's been vibe coding that tracks the origin of every piece of text—whether it was written by a human or generated by AI—and lets users ...

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma We conducted ...

Hepatoid adenocarcinoma of the stomach (HAS) is a rare histologic subtype of gastric cancer with distinct pathological features and poor prognosis. Surgery and chemotherapy remain the primary ...

Reply to: Can Pathologic Complete Response Serve as a Valid Surrogate End Point? The following represents disclosure information provided by the author of this manuscript. All relationships are ...

SECAUCUS, N.J., Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Pierre Fabre Pharmaceuticals, Inc. received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) stating ...

A June 2025 clip of Florida Governor Ron DeSantis discussing self-defense ahead of “No Kings” protests has been miscaptioned online as him defending the woman fatally shot by a U.S. immigration agent ...

Abstract: Organizations that transition to microservices architectures see their API count rise quickly because they must continuously create and modify APIs through decomposition and evolution and ...

1West German Study Group, Moenchengladbach, Germany. 2Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany. 3Department of Obstetrics and ...

Python’s popularity is surging. In 2025, it achieved a record 26.14% TIOBE index rating, the highest any language has ever reached, largely driven by AI and data trends. 58% of developers now use ...

NBEMS Exam Calendar 2026: The National Board of Examinations in Medical Sciences (NBEMS) has released the 2026 examination schedule today, December 29, 2025. Candidates aiming to appear for any of the ...

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies. Achieving complete response/remission (CR) is a reasonable surrogate ...